SEATTLE--(BUSINESS WIRE)--Mitopharm Corporation, Inc. (Pink Sheets:MTPM), releases the results of a research paper where Professor Dr. Robert Ko reports on defining the molecular features of Schisandrin B, the precursor of (-) Schisandrin B - a novel discovery by Dr. Ko – which are responsible for the beneficial effects on Myocardial Ischemia-Reperfusion.
